DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 146 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2020. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $213 | -99.9% | 20,060 | -1.0% | 0.00% | 0.0% |
| Q3 2022 | $211,000 | +93.6% | 20,263 | +133.0% | 0.00% | 0.0% |
| Q2 2022 | $109,000 | +18.5% | 8,697 | +2.3% | 0.00% | – |
| Q1 2022 | $92,000 | -22.7% | 8,500 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $119,000 | -27.0% | 8,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $163,000 | – | 8,500 | +5885.9% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 142 | -96.4% | 0.00% | – |
| Q2 2020 | $35,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |